Publication: In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with 225Ac
The JRC published a study on a new type of targeted cancer treatment that uses radioactive antibodies to attack tumors with a HER2 marker. The treatment showed strong stability and effectiveness...
HADEA’s Presence During the European Week Against Cancer
From May 25 to 31, European Health and Digital Executive Agency (HaDEA) joined partners across Europe to mark the European Week Against Cancer, promoting prevention...
29 Cancer Inequalities Factsheets Now Available on ECIR
A set of 29 country-specific cancer inequalities factsheets has been published on the European Cancer Inequalities Registry (ECIR). These factsheets present the key findings of the EU-CanIneq...